If you are not able to view this e-mail properly, please click here to view it online
World Pharma Today Maqazine
World Pharma Today Linkedin Page World Pharma Today Facebook Page World Pharma Today Twitter Page DOWNLOAD
Click here to subscribe to our Magazine
Independent Expert Committees
imange on World Pharma Today e-newsletter Featured Articles
Tracelink  serialization

Is the market now DSCSA ready?

In November 2017, the pharma industry was granted an extension of the Drug Supply Chain Security Act (DSCSA) enforcement date to November 2018. Regulators told the market that they would not actively enforce the new serialization requirements...


Looking Towards the Future: Worldwide Biosimilar Uptake and Pricing

Whereas generic drugs are identical copycats of small molecule chemical products, biosimilars are only similar to biologic products; innately more complex than chemical products, biologics are large molecule, organic drugs, subject to natural variability...


Dash to Serialization Implementation: The European Falsified Medicines Directive (FMD) Countdown for Indian Pharma Manufacturers

Compliance is a serious issue for India's pharmaceutical manufacturers, distributors, and retailers; due to the complicated nature...

imange on World Pharma Today e-newsletter Magazine e-book

Streamlining Supply Chain for Better Connect

View E-Book
World Pharma Today magazine
imange on World Pharma Today monthly e-newsletter Top Releases

Yusen Logistics

Yusen Logistics is the first Japanese air freight forwarder at Kansai International Airport to be awarded the prestigious IATA-CEIV Pharma certification

CEIV Pharma certification is a quality assurance program for the temperature controlled transportation of pharmaceutical products , developed by the IATA.


Almac Group Invests in Cutting Edge Next Generation Sequencing Capabilities for Bio Pharma Clients

Almac Diagnostic Services, a global stratified medicine company specialising in biomarker driven clinical trials, has made a significant investment in a new Illumina NovaSeq 6000 sequencer which will benefit...


Sandoz announces global resolution of biosimilar adalimumab patent disputes, securing patient access

Sandoz, a Novartis division and the global leader in biosimilars, announced a global resolution of all intellectual property (IP) related litigation with AbbVie concerning the proposed Sandoz biosimilar Hyrimoz...


For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2018 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com

World Pharma Today